ISO/TC 212 WG1 started the activity “13.3 Harmonization of terminology across ISO TC212”
CLSI changed all titles related to collection from “primary samples” to “specimen”.
ISO/DIS 15189 has 6.3.5 “Specimen collection facilities”
ISO 6717:2021 has: “3.17 specimen… [SOURCE: ISO 15189:2012, 3.16, modified – the preferred term 'primary sample' has been deleted.]”
ISO 20916:2019 3.47 specimen … [SOURCE:ISO 18113-1:2009, 3.54, modified — “Specimen” is the first preferred terms,
The International Medical Device Regulators Forum (IMDRF) uses the term specimen. 1 WHO uses the term “specimen”. 2 CLSI in many documents uses the term “specimen”. 3 ILAC uses the term “specimen” in G18 and G26. 4
CDC uses the term “specimen”.5 ISO itself in several documents uses the term specimen even in the title.6
Therefore, "specimen” is the standard term in collection activities. “primary sample” is little more than a form of "slang"and can cause confusion with other terms.
“sample” retains its value for statistical and measurement activities.
1Principles of In Vitro Diagnostic (IVD) Medical Devices Classification. Authoring Group: IMDRF IVD Working Group. Date: 21 January 2021 Common Data Elements for Medical Device Identification. Authoring Group: IMDRF RPS Working Group. Date: 24 March 2016 GHTF SG5 Clinical Performance Studies for IVD Medical Devices
GHTF SG1 - Summary Technical Documentation (STED) for Demonstrating Conformity to the Essential Principles of Safety and Performance of In Vitro Diagnostic Medical Devices - 17 March 2011
GHTF SG1 - Principles of Safety and Performance of Medical Devices - May 2005
Glossary and Definitions of Terms Used in GHTF Documents
GHTF SG1 Definition of the Terms Medical Device' and In Vitro Diagnostics' Medical Device's
2World Health Organization. Regional Office for the Eastern Mediterranean. (1995). Specimen collection and transport for microbiological investigation. https://apps.who.int/iris/handle/10665/119529 WHO Procedures for collection of clinical specimens (blood sample) during field investigation of suspected outbreaks. https://www.who.int/csr/resources/publications/ebola/blood-collect-en.pdf WHO/CDS/CSR/EDC/2000.4 Guidelines for the collection of clinical specimens during field investigation of outbreaks. https://apps.who.int/iris/bitstream/handle/10665/66348/WHO_CDS_CSR_EDC_2000.4.pdf?sequence=1
3EP35 Assessment of Equivalence or Suitability of Specimen Types for Medical Laboratory Measurement Procedures M54-A Principles and Procedures for Detection of Fungi in Clinical Specimens—Direct Examination and Culture; Approved Guideline AUTO01-A Laboratory Automation: Specimen Container/Specimen Carrier; Approved Standard
AUTO02-A2 Laboratory Automation: Bar Codes for Specimen Container Identification; Approved Standard—Second Edition
AUTO07-A Laboratory Automation: Data Content for Specimen Identification; Approved Standard
AUTO12-A Specimen Labels: Content and Location, Fonts, and Label Orientation; Approved Standard
GP23-Ed2 Nongynecological Cytology Specimens: Preexamination, Examination, and Postexamination Processes, Second Edition
GP34-A Validation and Verification of Tubes for Venous and Capillary Blood Specimen Collection; Approved Guideline
GP39-A6 Tubes and Additives for Venous and Capillary Blood Specimen Collection; Approved Standard—Sixth Edition
GP41-Ed7 Collection of Diagnostic Venous Blood Specimens, Seventh Edition
GP42-A6 Procedures and Devices for the Collection of Diagnostic Capillary Blood Specimens; Approved Standard—Sixth Edition
GP44-A4 Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests; Approved Guideline—Fourth Edition
H21-A5 Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline—Fifth Edition
M54-A Principles and Procedures for Detection of Fungi in Clinical Specimens—Direct Examination and Culture; Approved Guideline
MM13-A Collection, Transport, Preparation, and Storage of Specimens for Molecular Methods; Approved Guideline
4ILAC G26:11/2018 Guidance for the Implementation of a Medical Accreditation Scheme ILAC G18:04/2010 Guideline for the Formulation of Scopes of Accreditation for Laboratories
5CDC. Specimen Collection Guidelines. https://www.cdc.gov/urdo/downloads/speccollectionguidelines.pdf CDC. Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19 Testing. Updated Feb. 26, 2021. https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html Submitting Specimens to CDC. https://www.cdc.gov/laboratory/specimen-submission/list.html
6ISO (revised)
ISO 20916, In vitro diagnostic medical devices — Clinical performance studies using specimens from human subjects — Good study practice
ISO/DIS 4307 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for saliva — Isolated human DNA (14 recurrences)
ISO 6710:2017 Single-use containers for human venous blood specimen collection
ISO/FDIS 6717 In Vitro Diagnostic Medical Devices — Single-Use Containers For The Collection Of Specimens From Humans Other Than Blood
ISO 14971:2019 Medical devices — Application of risk management to medical devices. 3.7 3.10
ISO 16142-1:2016 Medical devices — Recognized essential principles of safety and performance of medical devices — Part 1: General essential principles and additional specific essential principles for all non-IVD medical devices and guidance on the selection of standards. 3.9 3.12
ISO 17511:2020 In vitro diagnostic medical devices — Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples. Scope, 3.21
ISO 17822:2020 In vitro diagnostic test systems — Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens — Laboratory quality practice guide. 3.30, 3.22,
ISO 18113-1:2009 In vitro diagnostic medical devices — Information supplied by the manufacturer (labelling) — Part 1: Terms, definitions and general requirements. 3.2
ISO 23640:2011 In Vitro Diagnostic Medical Devices — Evaluation Of Stability Of In Vitro Diagnostic Reagents. Scope, 3.6
ISO 21474-1:2020 In Vitro Diagnostic Medical Devices — Multiplex Molecular Testing For Nucleic Acids — Part 1: Terminology And General Requirements For Nucleic Acid Quality Evaluation. Introduction, 3.39
ISO 16142-2:2017 Medical devices — Recognized essential principles of safety and performance of medical devices — Part 2: General essential principles and additional specific essential principles for all IVD medical devices and guidance on the selection of standards. 3.10, 3.13,
ISO 20184-1:2018 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 1: Isolated RNA. Introduction, 3.12
ISO 20184-2:2018 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 2: Isolated proteins. Introduction, 1 Scope, 3.8
ISO 20186-2:2019 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 2: Isolated genomic DNA. Introduction, 3.18 Note1 and Note 2.
ISO 20186-3:2019 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 3: Isolated circulating cell free DNA from plasma. Introduction, 3.21.
ISO 20166-1:2018 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 1: Isolated RNA. Introduction, 1 Scope, 3.13, 3.14.
ISO 20166-2:2018 Molecular in vitro diagnostic examinations — Specifications for pre-examinations processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 2: Isolated proteins. Introduction, 1 Scope, 3.10,
ISO 20166-3:2018 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 3: Isolated DNA. Introduction, 3.12.
ISO 20916:2019 In vitro diagnostic medical devices — Clinical performance studies using specimens from human subjects — Good study practice
ISO 22367:2020 Medical laboratories — Application of risk management to medical laboratories. 3.10,
ISO 23640:2011 In vitro diagnostic medical devices — Evaluation of stability of in vitro diagnostic reagents. 1 Scope, 3.6,
CEN
FprCEN/TS 17742:2021 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Isolated circulating cell free RNA from plasma. 1 Scope
FprCEN/TS 17747:2021 Molecular in vitro diagnostic examinations – Specifications for pre-examination processes for exosomes and other extracellular vesicles in venous whole blood - DNA, RNA and proteins. "specimen" 50 recurrences
HL7
HL7 FHIR (Fast Healthcare Interoperability Resources). 10.7 Resource Specimen - Content. http://www.hl7.org/fhir/specimen.html
ISO/FDIS 6717:2021: 3.17 specimen
RispondiEliminadiscrete portion of a body fluid, breath, hair or tissue taken for examination, study or analysis of one or more quantities or properties assumed to apply for the whole
[SOURCE: ISO 15189:2012, 3.16, modified – the preferred term 'primary sample' has been deleted.]
FprCEN/TS 17742:2021 (E)
RispondiElimina"1 Scope
This document specifies requirements and recommendations for the pre-examination phase of circulating cell free RNA (ccfRNA) from venous whole blood specimens, including but not limited to the collection, handling, storage, processing and documentation of venous whole blood specimens intended for ccfRNA examination. This document covers specimens collected in venous whole blood collection
tubes."
FHIR (Fast Healthcare Interoperability Resources)
RispondiElimina10.7 Resource Specimen - Content
http://www.hl7.org/fhir/specimen.html
FprCEN/TS 17747:2021
RispondiElimina...pre-examination process, including the specimen collection, transport, storage and processing
FprCEN/TS 17747:2021
RispondiElimina"specimen" 50 recurrences
"primary sample" 5 recurrences, only 2 in text, 3 in Terms and definitions